NDC 51759-505 – Selarsdi
Ustekinumab-aekn 45 mg/.5mL · Injection, Solution · Subcutaneous
Product NDC51759-505
Product details
- Brand name
- Selarsdi
- Generic name
- Ustekinumab-aekn
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761343
- Marketed since
- March 12, 2025
- Listing expires
- December 31, 2027
- Pharmacologic class
- Interleukin-12 Antagonist; Interleukin-23 Antagonist
Active ingredients
- Ustekinumab-aekn 45 mg/.5mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 51759-505-13 | 1 VIAL in 1 CARTON (51759-505-13) / .5 mL in 1 VIAL | Oct 16, 2025 |
| 51759-505-32 | 1 TRAY in 1 CARTON (51759-505-32) / 1 SYRINGE, GLASS in 1 TRAY / .5 mL in 1 SYRINGE, GLASS | Mar 12, 2025 |
Other Selarsdi products
- 50090-7769 Ustekinumab 90 mg/mL · Injection, Solution · A-S Medication Solutions
- 51759-607 Ustekinumab-aekn 90 mg/mL · Injection, Solution · Teva Pharmaceuticals USA, Inc.
- 51759-708 Ustekinumab-aekn 130 mg/26mL · Injection, Solution · Teva Pharmaceuticals USA, Inc.